Profile data is unavailable for this security.
About the company
CONMED Corporation is a medical technology company, which provides surgical devices and equipment for minimally invasive procedures. Its products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine and lower extremities instrumentation and implants, small bone, large bone, and specialty powered surgical instruments as well as imaging systems for use in minimally invasive surgery procedures and fees related to the sales representation, promotion, and marketing of sports medicine allograft tissue. General surgery consists of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.
- Revenue in USD (TTM)1.26bn
- Net income in USD82.35m
- Incorporated2020
- Employees4.00k
- LocationConmed Corp11311 Concept BoulevardLARGO 33773United StatesUSA
- Phone+1 (727) 214-2974
- Fax+1 (302) 655-5049
- Websitehttps://www.conmed.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Establishment Labs Holdings Inc | 155.79m | -82.76m | 1.49bn | 781.00 | -- | 26.07 | -- | 9.54 | -3.15 | -3.15 | 5.91 | 2.07 | 0.6095 | 0.9191 | 3.39 | 171,579.30 | -32.38 | -33.22 | -39.25 | -41.12 | 65.01 | 64.73 | -53.12 | -43.19 | 2.73 | -21.30 | 0.7715 | -- | 2.13 | 21.96 | -4.38 | -- | 69.16 | -- |
| Alphatec Holdings Inc | 511.63m | -191.60m | 1.54bn | 839.00 | -- | 41.83 | -- | 3.02 | -1.49 | -1.49 | 3.97 | 0.4294 | 0.7612 | 1.34 | 6.70 | 609,808.10 | -28.51 | -30.97 | -37.13 | -39.47 | 65.89 | 66.02 | -37.45 | -46.22 | 1.49 | -5.17 | 0.8938 | -- | 37.45 | 39.38 | -23.36 | -- | 67.92 | -- |
| Inmode Ltd | 466.26m | 181.11m | 1.61bn | 581.00 | 9.02 | 1.93 | 8.85 | 3.45 | 2.11 | 2.11 | 5.42 | 9.87 | 0.5973 | 1.71 | 16.09 | 802,509.40 | 23.20 | 31.32 | 25.21 | 35.64 | 83.10 | 84.46 | 38.84 | 39.65 | 12.66 | -- | 0.00 | 0.00 | 8.32 | 37.49 | 22.54 | 54.65 | 13.10 | -- |
| LeMaitre Vascular Inc | 199.89m | 33.95m | 1.78bn | 614.00 | 52.60 | 5.78 | 40.97 | 8.92 | 1.51 | 1.51 | 8.89 | 13.74 | 0.5977 | 1.17 | 7.19 | 325,548.90 | 10.15 | 9.02 | 10.99 | 9.93 | 66.45 | 65.83 | 16.99 | 15.45 | 5.31 | -- | 0.00 | 40.41 | 19.69 | 12.88 | 45.89 | 5.96 | 18.93 | 15.51 |
| UFP Technologies Inc | 407.33m | 47.88m | 1.98bn | 3.09k | 41.57 | 6.71 | 33.27 | 4.86 | 6.21 | 6.21 | 52.82 | 38.46 | 1.02 | 4.50 | 6.71 | 131,693.20 | 11.99 | 9.69 | 13.80 | 10.95 | 27.89 | 26.33 | 11.75 | 10.14 | 1.46 | 17.87 | 0.1039 | 0.00 | 13.08 | 16.00 | 7.50 | 25.71 | 14.08 | -- |
| Warby Parker Inc | 697.80m | -55.06m | 1.98bn | 2.14k | -- | 6.27 | -- | 2.84 | -0.467 | -0.467 | 5.91 | 2.66 | 1.21 | 5.19 | 655.52 | 326,074.80 | -9.57 | -- | -11.95 | -- | 55.01 | 57.49 | -7.89 | -14.53 | 2.02 | -- | 0.00 | -- | 11.98 | 19.67 | 42.75 | -- | -- | -- |
| Premier Inc | 1.34bn | 80.33m | 2.05bn | 2.80k | 30.43 | 1.06 | 10.41 | 1.53 | 0.6421 | 0.6421 | 11.34 | 18.35 | 0.3887 | 5.25 | 3.10 | 477,306.10 | 1.89 | 10.39 | 2.48 | 13.00 | 66.20 | 62.04 | 4.87 | 22.60 | 0.8226 | 143.62 | 0.276 | 19.11 | -6.76 | 2.44 | -34.17 | -15.30 | -2.29 | -- |
| STAAR Surgical Co | 326.24m | 15.30m | 2.10bn | 1.06k | 138.36 | 5.35 | 101.60 | 6.45 | 0.3093 | 0.3093 | 6.62 | 8.00 | 0.7159 | 2.11 | 5.09 | 308,942.30 | 3.36 | 6.77 | 3.82 | 7.90 | 78.51 | 76.89 | 4.69 | 9.16 | 5.22 | -- | 0.0004 | 0.00 | 13.37 | 21.07 | -46.18 | 33.85 | 51.95 | -- |
| Patterson Companies, Inc. | 6.57bn | 193.86m | 2.26bn | 7.60k | 12.43 | 2.34 | 8.07 | 0.3441 | 2.03 | 2.03 | 68.86 | 10.78 | 2.23 | 5.61 | 14.48 | 864,047.90 | 6.58 | 0.3702 | 11.30 | 0.5655 | 21.30 | 21.05 | 2.95 | 0.1811 | 0.7243 | 12.08 | 0.4462 | 846.10 | -0.4298 | 3.44 | 2.14 | 10.79 | 8.22 | 0.00 |
| Conmed Corp | 1.26bn | 82.35m | 2.32bn | 4.00k | 28.73 | 2.71 | 15.03 | 1.84 | 2.62 | 2.62 | 40.12 | 27.76 | 0.545 | 1.73 | 5.55 | 315,387.00 | 3.56 | 0.8972 | 4.10 | 1.02 | 54.92 | 54.95 | 6.53 | 1.65 | 1.08 | 3.65 | 0.5369 | 139.16 | 19.06 | 7.68 | 179.99 | 10.04 | 2.89 | 0.00 |
| ICU Medical Inc | 2.26bn | -59.31m | 2.52bn | 14.00k | -- | 1.22 | 14.77 | 1.11 | -2.46 | -2.46 | 93.27 | 84.87 | 0.5154 | 2.12 | 15.86 | 161,223.70 | -1.35 | 1.46 | -1.51 | 1.65 | 32.48 | 34.11 | -2.63 | 2.23 | 1.09 | 0.4817 | 0.4393 | 0.00 | -0.9154 | 10.04 | 60.08 | -- | -1.45 | -- |
| Helen of Troy Limited | 2.01bn | 168.59m | 2.53bn | 1.93k | 15.09 | 1.54 | 11.51 | 1.26 | 7.05 | 7.05 | 83.65 | 68.94 | 0.6971 | 2.48 | 5.19 | 1,040,503.00 | 5.86 | 7.69 | 6.90 | 9.53 | 47.31 | 44.32 | 8.41 | 9.24 | 0.9936 | 5.27 | 0.289 | -- | -3.26 | 5.09 | 17.67 | -0.6548 | 6.79 | -- |
| Inari Medical Inc | 520.66m | -23.62m | 2.68bn | 1.30k | -- | 5.98 | -- | 5.15 | -0.409 | -0.409 | 8.95 | 7.71 | 0.8913 | 1.58 | 7.75 | 400,506.90 | -4.04 | -0.5941 | -4.57 | -0.6696 | 87.67 | 89.06 | -4.54 | -0.6295 | 2.19 | -- | 0.00 | -- | 28.73 | 135.40 | 94.41 | -- | 52.46 | -- |
| Enovis Corp | 1.82bn | -103.33m | 2.81bn | 6.55k | -- | 0.8479 | 20.68 | 1.54 | -1.89 | -1.50 | 33.29 | 60.33 | 0.3717 | 1.49 | 5.49 | 277,452.20 | -2.10 | -0.3569 | -2.32 | -0.41 | 58.12 | 48.19 | -5.66 | -1.06 | 1.03 | 0.9243 | 0.2879 | -- | 9.22 | -4.89 | -40.29 | -- | 11.91 | -- |
| Tandem Diabetes Care Inc | 770.01m | -141.45m | 3.05bn | 2.40k | -- | 12.55 | -- | 3.96 | -2.17 | -2.17 | 11.82 | 3.76 | 0.8126 | 2.74 | 8.35 | 320,837.10 | -14.93 | -10.08 | -18.48 | -12.23 | 49.28 | 51.77 | -18.37 | -11.59 | 3.01 | -- | 0.5884 | -- | -6.68 | 32.39 | -135.33 | -- | 76.81 | -- |
| Envista Holdings Corp | 2.56bn | -120.40m | 3.14bn | 12.80k | -- | 0.7586 | 288.06 | 1.23 | -0.713 | -0.713 | 14.72 | 24.09 | 0.3904 | 3.89 | 6.29 | 200,226.60 | -1.83 | 1.94 | -2.15 | 2.34 | 56.35 | 57.65 | -4.70 | 5.29 | 1.93 | 5.09 | 0.2667 | 0.00 | -0.1012 | -2.04 | -142.10 | -- | -4.22 | -- |
Data as of May 22 2024. Currency figures normalised to Conmed Corp's reporting currency: US Dollar USD
57.31%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 31 Mar 2024 | 4.64m | 15.06% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 3.37m | 10.94% |
| EARNEST Partners LLCas of 31 Mar 2024 | 2.37m | 7.70% |
| Capital Research & Management Co. (Global Investors)as of 31 Mar 2024 | 1.46m | 4.74% |
| Champlain Investment Partners LLCas of 31 Mar 2024 | 1.30m | 4.23% |
| SSgA Funds Management, Inc.as of 31 Mar 2024 | 1.22m | 3.95% |
| Managed Account Advisors LLCas of 31 Mar 2024 | 851.10k | 2.76% |
| Westwood Management Corp. (Texas)as of 31 Mar 2024 | 838.99k | 2.73% |
| Macquarie Investment Management Business Trustas of 31 Mar 2024 | 829.06k | 2.69% |
| Dimensional Fund Advisors LPas of 31 Mar 2024 | 770.98k | 2.50% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
